123 related articles for article (PubMed ID: 21269977)
1. [Oxidation status and γ-glutamylcysteine synthetase expression in the kidney of MRL/lpr lupus mice].
Chen RL; Tao Y; Zhang BP; Lv ZF
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):138-40. PubMed ID: 21269977
[TBL] [Abstract][Full Text] [Related]
2. Phase 2 enzyme induction by conjugated linoleic acid improves lupus-associated oxidative stress.
Bergamo P; Maurano F; Rossi M
Free Radic Biol Med; 2007 Jul; 43(1):71-9. PubMed ID: 17561095
[TBL] [Abstract][Full Text] [Related]
3. [Expression of STAT3 and PIAS3 in renal tissues of MRL/lpr mice].
Yang H; Xu A; Lv J; Liu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(6):821-5. PubMed ID: 22699062
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of lymphoid and renal interferon-gamma mRNA in autoimmune MRL-Fas(lpr) mice with lupus nephritis.
Fan X; Wüthrich RP
Inflammation; 1997 Feb; 21(1):105-12. PubMed ID: 9179626
[TBL] [Abstract][Full Text] [Related]
5. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
[TBL] [Abstract][Full Text] [Related]
6. [Changes of the activity and expression of gamma-glutamylcysteine synthetase in patients with chronic obstructive pulmonary disease].
Lin SD; Dai AG; Xu P
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):97-101. PubMed ID: 15854390
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
8. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
Boswell JM; Yui MA; Endres S; Burt DW; Kelley VE
J Immunol; 1988 Jul; 141(1):118-24. PubMed ID: 3259964
[TBL] [Abstract][Full Text] [Related]
9. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
10. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
[TBL] [Abstract][Full Text] [Related]
11. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis.
Wüthrich RP; Fan X; Ritthaler T; Sibalic V; Yu DJ; Loffing J; Kaissling B
Autoimmunity; 1998; 28(3):139-50. PubMed ID: 9867126
[TBL] [Abstract][Full Text] [Related]
12. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
[TBL] [Abstract][Full Text] [Related]
13. Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway.
You Y; Qin Y; Lin X; Yang F; Li J; Sooranna SR; Pinhu L
BMC Nephrol; 2015 Aug; 16():148. PubMed ID: 26310926
[TBL] [Abstract][Full Text] [Related]
14. [Expression of BATF, a member of the activator protein-1 family, in renal tissues of MRL/lpr mice].
Peng Y; Li Q; Wang M; Cao C; Lai K; Zeng K
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jun; 35(6):816-9. PubMed ID: 26111677
[TBL] [Abstract][Full Text] [Related]
15. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
Hasegawa H; Kohno M; Sasaki M; Inoue A; Ito MR; Terada M; Hieshima K; Maruyama H; Miyazaki J; Yoshie O; Nose M; Fujita S
Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475
[TBL] [Abstract][Full Text] [Related]
16. Enhanced hyaluronan synthesis in the MRL-Fas(lpr) kidney: role of cytokines.
Feusi E; Sun L; Sibalic A; Beck-Schimmer B; Oertli B; Wüthrich RP
Nephron; 1999 Sep; 83(1):66-73. PubMed ID: 10461038
[TBL] [Abstract][Full Text] [Related]
17. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.
Muraoka M; Hasegawa H; Kohno M; Inoue A; Miyazaki T; Terada M; Nose M; Yasukawa M
Arthritis Rheum; 2006 Nov; 54(11):3591-600. PubMed ID: 17075801
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of gamma-glutamylcysteine synthetase mRNA in rat kidney by methyl mercury.
Woods JS; Davis HA; Baer RP
Arch Biochem Biophys; 1992 Jul; 296(1):350-3. PubMed ID: 1351382
[TBL] [Abstract][Full Text] [Related]
19. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis.
Rops AL; van den Hoven MJ; Bakker MA; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; van der Vlag J; Berden JH
Nephrol Dial Transplant; 2007 Jul; 22(7):1891-902. PubMed ID: 17550924
[TBL] [Abstract][Full Text] [Related]
20. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
